Scott, I., N. Oden, P. VanVeldhuisen, M. Ip, and B. Blodi. SCORE2 Report 20: Relationship of Treatment Discontinuation With Visual Acuity and Central Subfield Thickness Outcomes. AM J Ophthalmol., 2023, p. Epub PubMed Text.
Abstract
Purpose: To investigate the relationship of anti-vascular endothelial growth factor (anti-VEGF) treatment discontinuation with baseline factors and outcomes in eyes treated initially with aflibercept or bevacizumab for macular edema from central or hemiretinal vein occlusion.